Registered entities
CATALENT, INC
Reg. No. 1596783United States
Catalent, Inc.
Reg. No. 208737688United States
Catalent Pharma Solutions, Inc.
Reg. No. 133523163United States
CATALENT PHARMA SOLUTIONS
Reg. No. 0800.771.523Belgium
Web presence
Audience by country — top 5 markets by share of visits.
| Country | Share |
|---|---|
| United States | 47.9% |
| India | 12.3% |
| Brazil | 7.5% |
| Argentina | 7.2% |
| United Kingdom | 5.1% |
Investor mix
6 investors on record; lead investors include Aisling Capital; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 3 | 50% |
| Accelerator & incubator | 1 | 17% |
| Bank & private debt | 1 | 17% |
| Other / undisclosed | 1 | 17% |
Share of voice
Share of voice in United States: 98.7% of web traffic across its competitive set; worldwide: 37.1%.
Hiring activity
Hires frequently
241 roles tracked across 9 of the last 12 months
11 Jun 2026 · Manager, Supply Chain · Kansas City
10 Jun 2026 · Manager, Drug Enforcement Administration · Kansas City
10 Jun 2026 · Director, Quality · Kansas City
10 Jun 2026 · Director, Quality Engineering · St. Petersburg
10 Jun 2026 · Pre-Production Coordinator · Kansas City
Based on job postings tracked across public sources.